APA (7th ed.) Citation

Attaran, F., Emami, S., Sohrabi, M., Malek, M., Ajdarkosh, H., Khoonsari, M., . . . Khamseh, M. E. (2023). Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: A randomized single-blind clinical trial. BMC.

Chicago Style (17th ed.) Citation

Attaran, Fereshte, Sepideh Emami, Masoudreza Sohrabi, Mojtaba Malek, Hossein Ajdarkosh, Mahmoodreza Khoonsari, Faramarz Ismail-Beigi, and Mohammad E. Khamseh. Effect of Empagliflozin and Pioglitazone on Left Ventricular Function in Patients with Type Two Diabetes and Nonalcoholic Fatty Liver Disease Without Established Cardiovascular Disease: A Randomized Single-blind Clinical Trial. BMC, 2023.

MLA (9th ed.) Citation

Attaran, Fereshte, et al. Effect of Empagliflozin and Pioglitazone on Left Ventricular Function in Patients with Type Two Diabetes and Nonalcoholic Fatty Liver Disease Without Established Cardiovascular Disease: A Randomized Single-blind Clinical Trial. BMC, 2023.